UniProt ID | ARBK1_HUMAN | |
---|---|---|
UniProt AC | P25098 | |
Protein Name | Beta-adrenergic receptor kinase 1 | |
Gene Name | GRK2 {ECO:0000312|HGNC:HGNC:289} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 689 | |
Subcellular Localization | Cytoplasm . Cell membrane . | |
Protein Description | Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner. [PubMed: 19306925] | |
Protein Sequence | MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADLEAVLA ------CCHHHHHHH | 30.05 | - | |
13 | Phosphorylation | AVLADVSYLMAMEKS HHHHHHHHHHHHHHC | 10.59 | 16725308 | |
19 | Ubiquitination | SYLMAMEKSKATPAA HHHHHHHHCCCCHHH | 44.14 | 17006543 | |
21 | Ubiquitination | LMAMEKSKATPAARA HHHHHHCCCCHHHHH | 68.31 | 17006543 | |
29 | Phosphorylation | ATPAARASKKILLPE CCHHHHHCCHHHCCC | 29.00 | 22817900 | |
30 | Ubiquitination | TPAARASKKILLPEP CHHHHHCCHHHCCCH | 42.73 | 17006543 | |
31 | Ubiquitination | PAARASKKILLPEPS HHHHHCCHHHCCCHH | 35.77 | 17006543 | |
38 | Phosphorylation | KILLPEPSIRSVMQK HHHCCCHHHHHHHHH | 29.04 | 28450419 | |
41 | Phosphorylation | LPEPSIRSVMQKYLE CCCHHHHHHHHHHHH | 21.92 | 23090842 | |
45 | Ubiquitination | SIRSVMQKYLEDRGE HHHHHHHHHHHHCCC | 33.44 | - | |
50 | Methylation | MQKYLEDRGEVTFEK HHHHHHHCCCCCHHH | 33.52 | - | |
54 | Phosphorylation | LEDRGEVTFEKIFSQ HHHCCCCCHHHHHHH | 23.06 | 23090842 | |
57 | Ubiquitination | RGEVTFEKIFSQKLG CCCCCHHHHHHHHHH | 44.88 | 21890473 | |
62 | Ubiquitination | FEKIFSQKLGYLLFR HHHHHHHHHHHHHHH | 42.56 | 21890473 | |
86 | Phosphorylation | ARPLVEFYEEIKKYE HHHHHHHHHHHHHHH | 10.11 | 16725308 | |
92 | Phosphorylation | FYEEIKKYEKLETEE HHHHHHHHHCCCCHH | 17.19 | 16725308 | |
94 | Ubiquitination | EEIKKYEKLETEEER HHHHHHHCCCCHHHH | 48.83 | - | |
115 | Ubiquitination | IFDSYIMKELLACSH HHHHHHHHHHHHCCC | 35.33 | - | |
126 | Ubiquitination | ACSHPFSKSATEHVQ HCCCCCCHHHHHHHH | 44.48 | - | |
138 | Ubiquitination | HVQGHLGKKQVPPDL HHHHCCCCCCCCHHH | 46.52 | - | |
139 | Ubiquitination | VQGHLGKKQVPPDLF HHHCCCCCCCCHHHH | 55.52 | - | |
164 | Ubiquitination | LRGDVFQKFIESDKF CCCCHHHHHHHCCCC | 36.52 | - | |
164 | Acetylation | LRGDVFQKFIESDKF CCCCHHHHHHHCCCC | 36.52 | 26822725 | |
170 | Ubiquitination | QKFIESDKFTRFCQW HHHHHCCCCCEECCC | 58.89 | 21890473 | |
206 | Phosphorylation | RGGFGEVYGCRKADT CCCCCCCCCCCCCCC | 13.25 | - | |
213 | Phosphorylation | YGCRKADTGKMYAMK CCCCCCCCCCEEEEH | 43.49 | 22964224 | |
215 | Ubiquitination | CRKADTGKMYAMKCL CCCCCCCCEEEEHHH | 30.72 | - | |
220 | Ubiquitination | TGKMYAMKCLDKKRI CCCEEEEHHHCHHHC | 24.39 | - | |
230 | Ubiquitination | DKKRIKMKQGETLAL CHHHCCCCCCCEEEE | 50.58 | - | |
247 | Phosphorylation | RIMLSLVSTGDCPFI HHHHHHHCCCCCCEE | 31.78 | 22817900 | |
248 | Phosphorylation | IMLSLVSTGDCPFIV HHHHHHCCCCCCEEE | 29.56 | 22817900 | |
263 | Phosphorylation | CMSYAFHTPDKLSFI EEEHHCCCCCHHHHH | 27.08 | 22817900 | |
319 | Ubiquitination | FVVYRDLKPANILLD EEEEECCCHHCEEEC | 46.50 | - | |
344 | Acetylation | GLACDFSKKKPHASV CEECCCCCCCCCCCC | 65.88 | 25953088 | |
344 | Ubiquitination | GLACDFSKKKPHASV CEECCCCCCCCCCCC | 65.88 | - | |
345 | Ubiquitination | LACDFSKKKPHASVG EECCCCCCCCCCCCC | 71.04 | - | |
346 | Ubiquitination | ACDFSKKKPHASVGT ECCCCCCCCCCCCCC | 45.85 | - | |
350 | Phosphorylation | SKKKPHASVGTHGYM CCCCCCCCCCCCCCC | 20.32 | 19369195 | |
353 | Phosphorylation | KPHASVGTHGYMAPE CCCCCCCCCCCCCHH | 15.24 | 22817900 | |
356 | Phosphorylation | ASVGTHGYMAPEVLQ CCCCCCCCCCHHHHH | 5.19 | - | |
389 | Phosphorylation | FKLLRGHSPFRQHKT HHHHHCCCHHHHCCC | 28.67 | 27067055 | |
416 | Phosphorylation | MAVELPDSFSPELRS EEEECCCCCCHHHHH | 26.19 | - | |
423 | Phosphorylation | SFSPELRSLLEGLLQ CCCHHHHHHHHHHHH | 50.35 | 21712546 | |
448 | Ubiquitination | GRGAQEVKESPFFRS CCCCHHHHHCCCHHC | 52.28 | - | |
487 | Phosphorylation | ADAFDIGSFDEEDTK HHCCCCCCCCCCCCC | 29.83 | 29978859 | |
493 | Phosphorylation | GSFDEEDTKGIKLLD CCCCCCCCCCEEEEC | 34.15 | 27732954 | |
494 | Ubiquitination | SFDEEDTKGIKLLDS CCCCCCCCCEEEECC | 71.59 | - | |
497 | Ubiquitination | EEDTKGIKLLDSDQE CCCCCCEEEECCCHH | 52.22 | - | |
501 | Phosphorylation | KGIKLLDSDQELYRN CCEEEECCCHHHHHH | 40.96 | 27067055 | |
506 | Phosphorylation | LDSDQELYRNFPLTI ECCCHHHHHHCCCCC | 11.62 | 29978859 | |
545 | Ubiquitination | ARKKAKNKQLGHEED HHHHHHHHCCCCHHH | 46.31 | - | |
557 | Ubiquitination | EEDYALGKDCIMHGY HHHHHCCHHHHHHHH | 50.72 | - | |
628 | Ubiquitination | LLKIRGGKQFILQCD EEEEECCCEEEEECC | 44.88 | - | |
644 | Ubiquitination | DPELVQWKKELRDAY CHHHHHHHHHHHHHH | 21.19 | - | |
644 | Acetylation | DPELVQWKKELRDAY CHHHHHHHHHHHHHH | 21.19 | 25953088 | |
670 | Phosphorylation | KMKNKPRSPVVELSK HHCCCCCCCCEEHHC | 30.49 | 29255136 | |
676 | Phosphorylation | RSPVVELSKVPLVQR CCCCEEHHCCCCEEC | 20.36 | 23927012 | |
677 | Ubiquitination | SPVVELSKVPLVQRG CCCEEHHCCCCEECC | 61.57 | 21890473 | |
683 | Methylation | SKVPLVQRGSANGL- HCCCCEECCCCCCC- | 33.29 | - | |
685 | Phosphorylation | VPLVQRGSANGL--- CCCEECCCCCCC--- | 22.28 | 28355574 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
13 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
29 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
29 | S | Phosphorylation | Kinase | PKCA | P05696 | PSP |
29 | S | Phosphorylation | Kinase | PRKCD | P09215 | GPS |
29 | S | Phosphorylation | Kinase | PRKCG | P05129 | GPS |
86 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
92 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
670 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
670 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
670 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
685 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
685 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:17006543 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARBK1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARBK1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GNAQ_HUMAN | GNAQ | physical | 12885252 | |
GNA15_HUMAN | GNA15 | physical | 12885252 | |
KPCB_HUMAN | PRKCB | physical | 12679936 | |
CNRG_HUMAN | PDE6G | physical | 12624098 | |
SRC_HUMAN | SRC | physical | 12624098 | |
PHLP_HUMAN | PDCL | physical | 10884381 | |
PHOS_HUMAN | PDC | physical | 10884381 | |
OPSD_HUMAN | RHO | physical | 10722682 | |
FSHR_HUMAN | FSHR | physical | 10379886 | |
HDAC6_HUMAN | HDAC6 | physical | 22193721 | |
MDM2_HUMAN | MDM2 | physical | 21081496 | |
ARRB1_HUMAN | ARRB1 | physical | 21081496 | |
GBB1_HUMAN | GNB1 | physical | 17548351 | |
GBB1_HUMAN | GNB1 | physical | 10744734 | |
CSEN_HUMAN | KCNIP3 | physical | 17102134 | |
ADRB2_HUMAN | ADRB2 | physical | 14654844 | |
PEBP1_HUMAN | PEBP1 | physical | 14654844 | |
EPHA2_HUMAN | EPHA2 | physical | 21988832 | |
RGRF1_HUMAN | RASGRF1 | physical | 21988832 | |
GNAQ_HUMAN | GNAQ | physical | 21940795 | |
RPGF3_MOUSE | Rapgef3 | physical | 20861385 | |
HS90A_HUMAN | HSP90AA1 | physical | 23455922 | |
HS90B_HUMAN | HSP90AB1 | physical | 23455922 | |
ARBK2_HUMAN | ADRBK2 | physical | 23455922 | |
ACACA_HUMAN | ACACA | physical | 23455922 | |
SYNM_HUMAN | NARS2 | physical | 26344197 | |
ARBK2_HUMAN | ADRBK2 | physical | 28514442 | |
GNAQ_HUMAN | GNAQ | physical | 10727532 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00171 | Adenosine triphosphate |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350 AND THR-353, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670, AND MASSSPECTROMETRY. |